We are live on ! Find out more
OAM

Oppenheimer Asset Management Portfolio holdings

AUM $9.63B
1-Year Est. Return 30.32%
This Fund
S&P 500
This Quarter Est. Return
+43.55%
1 Year Est. Return
+30.32%
3 Year Est. Return
+85%
5 Year Est. Return
+99.62%
10 Year Est. Return
+601.29%
AUM
$4.45B
AUM Growth
+$416M
Cap. Flow
-$282M
Cap. Flow %
-6.34%
Top 10 Hldgs %
16.83%
Holding
1,684
New
54
Increased
785
Reduced
692
Closed
80

Sector Composition

Rank Sector Weight
1 Technology 15.34%
2 Financials 13.53%
3 Healthcare 12.26%
4 Industrials 9.66%
5 Consumer Discretionary 8.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DVN icon
126
Devon Energy
DVN
$47.3B
$8.98M 0.2%
284,549
+94,796
+50% +$2.65M
VRTX icon
127
Vertex Pharmaceuticals
VRTX
$126B
$8.98M 0.2%
48,807
-3,805
-7% -$703K
ZBH icon
128
Zimmer Biomet
ZBH
$18.4B
$8.93M 0.2%
72,038
-30,719
-30% -$3.49M
CTSH icon
129
Cognizant
CTSH
$26B
$8.9M 0.2%
122,837
+20,596
+20% +$1.44M
EQH icon
130
Equitable Holdings
EQH
$14.1B
$8.69M 0.2%
431,398
+122,277
+40% +$2.33M
NBL
131
DELISTED
Noble Energy, Inc.
NBL
$8.52M 0.19%
344,367
+34,769
+11% +$787K
MET icon
132
MetLife
MET
$62.1B
$8.51M 0.19%
199,904
-97,214
-33% -$4.3M
ULTA icon
133
Ulta Beauty
ULTA
$24.3B
$8.48M 0.19%
24,308
-4,397
-15% -$1.33M
IWD icon
134
iShares Russell 1000 Value ETF
IWD
$83.7B
$8.47M 0.19%
68,617
-302,245
-81% -$36.3M
BURL icon
135
Burlington
BURL
$23.2B
$8.39M 0.19%
53,552
+16,374
+44% +$2.64M
AZN icon
136
AstraZeneca
AZN
$250B
$8.24M 0.19%
101,881
-2,357
-2% -$186K
GSK icon
137
GSK
GSK
$106B
$8.19M 0.18%
156,752
-18,534
-11% -$926K
AMGN icon
138
Amgen
AMGN
$222B
$8.18M 0.18%
43,036
-755
-2% -$144K
CVS icon
139
CVS Health
CVS
$122B
$8.08M 0.18%
149,829
+137,539
+1,119% +$8.49M
ABB
140
DELISTED
ABB Ltd
ABB
$8.03M 0.18%
425,759
+55,731
+15% +$1.08M
CNI icon
141
Canadian National Railway
CNI
$76.6B
$8.03M 0.18%
89,766
-12,922
-13% -$1.08M
BDX icon
142
Becton Dickinson
BDX
$48.2B
$7.99M 0.18%
32,784
-9,096
-22% -$2.15M
ADI icon
143
Analog Devices
ADI
$190B
$7.92M 0.18%
75,260
+2,791
+4% +$280K
APD icon
144
Air Products & Chemicals
APD
$67.6B
$7.92M 0.18%
41,478
-5,973
-13% -$1.03M
TPR icon
145
Tapestry
TPR
$32.8B
$7.91M 0.18%
243,395
+13,570
+6% +$476K
TAK icon
146
Takeda Pharmaceutical
TAK
$55.7B
$7.83M 0.18%
384,408
+74,247
+24% +$1.49M
ROL icon
147
Rollins
ROL
$18.2B
$7.83M 0.18%
282,167
+15,575
+6% +$405K
SLB icon
148
SLB Ltd
SLB
$75B
$7.68M 0.17%
176,261
+5,862
+3% +$253K
NVDA icon
149
NVIDIA
NVDA
$5.42T
$7.65M 0.17%
1,705,040
+173,360
+11% +$673K
BIDU icon
150
Baidu
BIDU
$37.2B
$7.61M 0.17%
46,158
-451
-1% -$75.5K

Similar funds

Oppenheimer Asset Management's Q1 2019 Portfolio in Review

As of Q1 2019, Oppenheimer Asset Management held 1,684 positions worth $4.45B, up 10% from $4.04B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Oppenheimer Asset Management withdrew a net $282M in Q1 2019, closing 80 positions and reducing 692 holdings. Its most notable exit was iShares Core Moderate Allocation ETF, an estimated $3.44M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Oppenheimer Asset Management opened a new position in First Trust Managed Municipal ETF worth $11.3M.

  • Oppenheimer Asset Management's largest Q1 2019 buy was First Trust Managed Municipal ETF: 209,351 shares worth $11.3M.
  • Oppenheimer Asset Management added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q1 2019, an estimated $21.9M increase.
  • Oppenheimer Asset Management's biggest Q1 2019 reduction was TotalEnergies, cutting an estimated $226M.
  • Oppenheimer Asset Management fully exited iShares Core Moderate Allocation ETF in Q1 2019, selling an estimated $3.44M.
  • Oppenheimer Asset Management's ten largest holdings make up 17% of its $4.45B portfolio in Q1 2019.
  • Oppenheimer Asset Management opened 54 new positions and closed 80 in Q1 2019.
  • Oppenheimer Asset Management's portfolio value rose 10% quarter-over-quarter to $4.45B.

Based on Oppenheimer Asset Management's 13F filing for Q1 2019, filed 24 Apr 2019.